The Pharmacy Times® Allergy Resource Center is a comprehensive resource for clinical news and expert insights on issues related to conditions that cause the immune system to react abnormally to a foreign substance, including seasonal allergies, food allergies, drug allergies, and contact dermatitis.
May 26th 2025
Pharmacists improve outcomes by clarifying and delabeling inaccurate antibiotic allergies.
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria
Published: April 18th 2025 | Updated: April 18th 2025Multiple phase 3 clinical trials demonstrated dupilumab’s (Dupixent; Regeneron, Sanofi) effectiveness in reducing hives and itch in patients with chronic spontaneous urticaria compared with placebo.
Read More